Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04516772 · ClinicalTrials.gov registry record · NA
STAAR Visian Toric ICL Post-Approval Study
A NA study, sponsored by Staar Surgical Company.
- Completed
- Registry status
- NA
- Development phase
- 125
- Enrollment target
NCT04516772: Completed NA study, sponsored by Staar Surgical Company.
NCT04516772 is a NA study that has completed, run by Staar Surgical Company. The registered enrollment target is 125 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04516772, a NA study, has completed, sponsored by Staar Surgical Company.
- COMPLETED
- Registry status
- NA
- Development phase
- 125 participants
- Enrollment target
Study Summary
The objective of this study is to evaluate the long term (i.e. 24 months) clinical performance of the Visian® Toric Implantable Collamer® Lens (ICL).
Interventions
- DEVICE Visian TICL
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2020-07-21 |
| Est. Completion | 2024-12-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04516772
The ClinicalTrials.gov registry entry for NCT04516772 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 125 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). The listed sponsor is Staar Surgical Company, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Visian TICL is the first listed.
NCT04516772 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04516772 about?
NCT04516772 is a clinical study titled "STAAR Visian Toric ICL Post-Approval Study". The objective of this study is to evaluate the long term (i.e. 24 months) clinical performance of the Visian® Toric Implantable Collamer® Lens (ICL).
What is the current status of trial NCT04516772?
This trial is currently completed. It is a NA study. The enrollment target is 125 participants. The study started on 2020-07-21. Estimated completion is 2024-12-11.
What interventions are being tested in trial NCT04516772?
The interventions under investigation include: Visian TICL (DEVICE).
Who is sponsoring clinical trial NCT04516772?
This trial is sponsored by Staar Surgical Company, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.